Teva's stunning list of cuts targets 14K jobs, $3B in costs and plants around the globe | Fierce Pharma
Teva Pharmaceutical: What To Expect In 2023 With New CEO (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Stock Plunges On Flat Sales, Earnings Disappointment | Investor's Business Daily
Teva Pharmaceuticals on X: "Teva just announced its Q4 and full year 2023 financial results. View the press release here: https://t.co/RZ6UsL39sy Forward-looking statements are subject to the cautionary note included in our
Teva Pharmaceuticals on X: "Teva just announced its Q2 2022 financial results. View the press release here: https://t.co/OGECc00hWU Forward-looking statements are subject to the cautionary note included in our Q2 2022 press
Teva Pharmaceutical says it will defend claims it was involved in price-fixing in the US
Teva enlarges workforce for first time since 2016 - Globes
DEF 14A
Teva Pharmaceutical net income 2006-2023 | Statista
Teva Pharma Q2 Revenues Drop 18% | BioSpace
Teva Completes Amendment to Credit Facilities
Teva Pharmaceutical Industries Ltd. - Investors
Teva Pharmaceuticals on X: "Yesterday we shared Teva's business results for the third quarter of 2023. Learn more here: https://t.co/A558XW4atM #QuarterlyResults #Earnings $Teva Forward-looking statements are subject to the cautionary note included
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by Wellington Management Group LLP
Form 10-K
Teva Pharmaceutical Industries (NYSE:TEVA) Has A Somewhat Strained Balance Sheet - Simply Wall St News